1. AHRO : Austin Health Research Online

Belinda Yeo

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Belinda Yeo
Full Name
Yeo, Belinda
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Yeo, Belinda
Author:  Pal, Bhupinder

Results 1-5 of 5 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
1Sep-2023Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.Whitfield, Holly J; Berthelet, Jean; Mangiola, Stefano; Bell, Caroline; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Papenfuss, Anthony T; Merino, Delphine; Davis, Melissa J
213-May-2022Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.Berthelet, Jean; Foroutan, Momeneh; Bhuva, Dharmesh D; Whitfield, Holly J; El-Saafin, Farrah; Cursons, Joseph; Serrano, Antonin; Merdas, Michal; Lim, Elgene; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Ernst, Matthias ; Hollande, Frédéric; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Davis, Melissa J; Merino, Delphine
32021The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.Berthelet, Jean; Wimmer, Verena C; Whitfield, Holly J; Serrano, Antonin; Boudier, Thomas; Mangiola, Stefano; Merdas, Michal; El-Saafin, Farrah; Baloyan, David; Wilcox, Jordan; Wilcox, Steven; Parslow, Adam C; Papenfuss, Anthony T; Yeo, Belinda ; Ernst, Matthias ; Pal, Bhupinder; Anderson, Robin L ; Davis, Melissa J; Rogers, Kelly L; Hollande, Frédéric; Merino, Delphine
4Mar-2019A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J
55-Dec-2018A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.Lindeman, Geoffrey J; Lok, Sheau Wen; Whittle, James R; Vaillant, Francois; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria J; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Zivanovic Bujak, Andjelija; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E